60% off Profit Pro - Limited Time Offer!
Adial Pharmaceuticals Inc
ADIL · NASDAQDay Range
52 Week Range
Market Cap
6.73MUSD
About
General Information
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00688A1060
CUSIP
00688A106
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
Highlights
PE Ratio
-
PEG Ratio
-
Book Value
2.46
Dividend Share
-
Dividend Yield
-
Earnings Share
-2.94
Wall Street Target Price
7.5
EPS Estimate Current Year
-2.775
EPS Estimate Next Year
-1.415
EPS Estimate Current Quarter
-0.44
EPS Estimate Next Quarter
-0.4
Most Recent Quarter
-
Profitability
Revenue TTM
0
Gross Profit TTM
0
EBITDA
-7,273,465
Profit Margin
0.00%
Return On Assets TTM
-104.18%
Return On Equity TTM
-320.96%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-2.94
Qtly Earnings Growth YOY
0.00%
Valuation
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0
Price Book MRQ
1.1432
Enterprise Value Revenue
0
Enterprise Value EBITDA
0
Peers analysis
- CSLLYCSL Ltd
88.70
1.04% - BNTXBioNTech SE
113.91
0.41% - VRTXVertex Pharmaceuticals Inc
408.14
0.05% - ARGNFargenx SE
630.00
0.00% - CMXHFCSL Limited
173.50
0.00%
- REGNRegeneron Pharmaceuticals Inc
714.47
0.00% - UCBJFUCB SA
198.28
0.00% - UCBJYUCB SA ADR
99.02
-0.96% - ALNYAlnylam Pharmaceuticals Inc
242.01
-0.60% - ARGXargenx NV ADR
629.00
-0.16%
